A Relação entre Diabetes Gestacional e Macrossomia Fetal: Consequências Obstétricas e Pediátricas
DOI:
https://doi.org/10.36557/2674-8169.2024v6n11p2862-2879Keywords:
Diabetes Gestacional, Macrossomia fetal, Complicações obstétricas, Impactos neonataisAbstract
INTRODUCTION: Gestational diabetes mellitus (GDM) is a condition of hyperglycemia during pregnancy, with risks for the mother and fetus. Its history has evolved over time, highlighting complications such as fetal macrosomia and cesarean section. METHOD: This study is an integrative review carried out in November 2024, with a search in PubMed using the descriptors "Gestacional Diabetes" AND "Fetal Macrossomia" and "Gestacional Diabetes" AND "Birth Complications". Six articles published between 2020 and 2024 were selected, in addition to the Official Guideline of the Brazilian Diabetes Society (2023). The data were analyzed and presented in thematic categories, addressing risk factors, impacts, and prevention and control approaches. RESULTS: The study investigated the relationship between gestational diabetes (GDM) and fetal macrosomia, identifying risk factors and strategies for predicting and managing the condition. The results revealed that maternal hyperglycemia, especially when uncontrolled, is strongly associated with an increased risk of fetal macrosomia. The analysis showed that pregnant women with GDM have a higher incidence of babies with birth weights greater than 4000 g, which increases obstetric complications, such as cesarean sections and shoulder dystocia. Strict glycemic control was highlighted as essential to reduce these risks. In addition, the study found that ultrasound and specific biomarkers, such as CLUL1 and VCAN, can improve the prediction of macrosomia in pregnant women with GDM. Continuous monitoring of glycemia, especially in the third trimester, was highlighted as an important strategy to prevent neonatal complications and improve perinatal outcomes, such as hypoglycemia and respiratory disorders in newborns. CONCLUSION: Gestational diabetes mellitus (GDM) is an obstetric challenge, with a risk of fetal macrosomia and complications. Glycemic control strategies, early diagnosis and integrated care improve maternal and neonatal outcomes.
Downloads
References
YE, Wenrui et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. Thebmj, [s. l.], 2021. DOI 10.1136/bmj-2021-067946. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35613728/. Acesso em: 1 nov. 2024.
SWEETING, Arianne et al. A Clinical Update on Gestational Diabetes Mellitus. Endocrine Reviws, [s. l.], 2022. DOI 10.1210/endrev/bnac003. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC9512153/. Acesso em: 1 nov. 2024
Zajdenverg L, Façanha C, Dualib P, Golbert A, Moisés E, Calderon I, Mattar R, Francisco R, Negrato C, Bertoluci M. Rastreamento e diagnóstico da hiperglicemia na gestação. Diretriz Oficial da Sociedade Brasileira de Diabetes (2023). DOI: 10.29327/557753.2022-11, ISBN: 978-85-5722-906-8.
Zajdenverg L, Façanha C, Dualib P, Goldbert A, Negrato C, Bertoluci M. Planejamento, metas e monitorização do diabetes durante a gestação. Diretriz Oficial da Sociedade Brasileira de Diabetes (2023). DOI: 10.29327/557753.2022-12, ISBN: 978-85-5722-906-8.
Zajdenverg L, Dualib P, Façanha C, Goldbert A, Negrato C, Forti A, Bertoluci M. Tratamento farmacológico do diabetes na gestação. Diretriz Oficial da Sociedade Brasileira de Diabetes (2023). DOI: 10.29327/557753.2022-13, ISBN: 978-85-5722-906-8.
Zhang Y, Chen L, Zhang L, Wu Y, Li L. Fasting plasma glucose and fetal ultrasound predict the occurrence of neonatal macrosomia in gestational diabetes mellitus. BMC Pregnancy Childbirth. 2023 Apr 19;23(1):269. doi: 10.1186/s12884-023-05594-6. PMID: 37076807; PMCID: PMC10114470.
Yuan Y, Zhu Q, Yao X, Shi Z, Wen J. Maternal circulating metabolic biomarkers and their prediction performance for gestational diabetes mellitus related macrosomia. BMC Pregnancy Childbirth. 2023 Feb 14;23(1):113. doi: 10.1186/s12884-023-05440-9. PMID: 36788507; PMCID: PMC9926775.
Oros Ruiz M, Perejón López D, Serna Arnaiz C, Siscart Viladegut J, Àngel Baldó J, Sol J. Maternal and foetal complications of pregestational and gestational diabetes: a descriptive, retrospective cohort study. Sci Rep. 2024 Apr 19;14(1):9017. doi: 10.1038/s41598-024-59465-x. PMID: 38641705; PMCID: PMC11031602.
Suda-Całus M, Dąbrowska K, Gulczyńska E. Infant of a diabetic mother: clinical presentation, diagnosis and treatment. Pediatr Endocrinol Diabetes Metab. 2024;30(1):36-41. doi: 10.5114/pedm.2024.137891. PMID: 39026477; PMCID: PMC11037090.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Naysa Gabrielly Alves de Andrade, Amanda Araújo de Sousa, Amanda= Martins Malaquias , Claudenice Antonia Aguiar Lima, Denise dos Anjos Neves, Fabrício Augusto Rodrigues de Castro , Jessica Fidelis trindade dos santos Trindade dos Santos , Juliana Oliveira do Nascimento , Lorrayne Sousa Pereira, Luciana dos Anjos Silva , Marystela Batista Martins , Matheus Felipe Rodrigues de Castro , Rafael Ambrosio Barreto, Yuri da Silva Pimenta

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.



